Immunovant, Inc. IMVT Balance Sheet Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| $902.11M+26.4% | $994.53M+165% | $521.87M+10.3% | $598.91M+6.9% | $713.97M+12.4% | ||
| $6.68M-22.3% | $7.63M-35.6% | $8.21M-22.9% | $8.12M-20.4% | $8.6M-0.1% | ||
| $948.82M+23.6% | $1.04B+153% | $573.55M+13.0% | $651.76M+10.6% | $767.66M+15.3% | ||
| $443K-47.5% | $531K-29.4% | $632K-5.8% | $737K+30.4% | $844K+82.7% | ||
| $957.01M+23.3% | $1.05B+150% | $582.96M+13.0% | $661.44M+12.2% | $776.22M+16.5% | ||
| $7.54M-57.3% | $8.62M-56.5% | $6.92M-66.6% | $7.84M-28.9% | $17.66M+147% | ||
| $104.42M+51.8% | $66.26M-3.0% | $63.25M-5.1% | $52.9M+17.5% | $68.78M+41.5% | ||
| $104.42M+51.8% | $66.26M-3.0% | $63.25M-5.1% | $52.9M+17.5% | $68.78M+41.5% | ||
| $20K+25.0% | $500M0.0% | $500M0.0% | $500M0.0% | $16K+14.3% | ||
| -$1.75B-40.8% | -$1.6B-41.0% | -$1.49B-45.5% | -$1.36B-49.0% | -$1.24B-50.1% | ||
| $852.59M+20.5% | $986.14M+180% | $519.71M+15.7% | $608.54M+11.7% | $707.45M+14.5% | ||
| $957.01M+23.3% | $1.05B+150% | $582.96M+13.0% | $661.44M+12.2% | $776.22M+16.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Immunovant, Inc.'s total assets?
- Immunovant, Inc. (IMVT) holds $957.0M in total assets, up 23.3% year over year.
- How much debt does Immunovant, Inc. have?
- Immunovant, Inc. carries $72.0K in total debt against $852.6M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Immunovant, Inc. have?
- Immunovant, Inc. holds $902.1M in cash and equivalents.
- Can Immunovant, Inc. cover its short-term obligations?
- Its current ratio is 9.09 — current assets exceed current liabilities.
- Where does Immunovant, Inc.'s balance sheet data come from?
- Every line is extracted from Immunovant, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.